A 19-year-old Tennessee college athlete nearly died from histoplasmosis after two months of misdiagnosis during a county ...

I found this issue’s cover story on the role of the microbiome in eye health and disease quite interesting. A normal ...

Under the right conditions, a human eye can look as if it is filled with tiny stars or shimmering tinsel. That sparkle is not ...

A small U.S. foreign aid program worked for nearly two decades to help countries eliminate tropical diseases that aren't known to many people. The Trump administration ended the program in January.

NASHVILLE, Tenn. (WSMV) - Middle Tennessee in recent weeks has seen a rise in cases of a fungal infection spread by breathing in spores, leading to many on social media pointing to “fog they create” ...

The Tennessee Department of Health has issued a health advisory after an increase in histoplasmosis cases in Williamson and Maury counties. Histoplasmosis is a lung infection, or pneumonia, caused by ...

NASHVILLE, Tenn. (WSMV) - The Tennessee Department of Health (TDH) is warning about a rise in cases involving a fungus in the Midstate. TDH is warning clinicians and laboratories of an increase in ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine AI-powered retinal imaging closes healthcare gaps, enables ...

Although ocular disease commonly occurs in people with rosacea, ocular rosacea remains underrecognized by dermatologists and even eye specialists, according to experts. Fortunately, an ophthalmologist ...

Share on Pinterest Eye health may hold the key to predicting heart disease and aging risk, according to new research. PeopleImages/Getty Images Scientists have known for some time now that the eyes ...

DURHAM, N.C. (WTVD) -- Duke Eye Center has become the first academic medical center in the country to implant a new cell-based gene therapy for a rare eye disease called MacTel. This procedure offers ...

During his tenure at Roche's Genentech, ophthalmologist Jason Ehrlich, M.D., Ph.D., supported the development of the blockbuster eye disease med Vabysmo (faricimab). Now, as the co-founder and CEO of ...